Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progr... 21/09/2026 Healthcare Drug discovery Personalized medicine In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe... Partners - ADmit Therapeutics
Viva in Vitro and Vall d’Hebron will investigate the potential of functional NLRP3 biomark... 07/09/2026 Healthcare Drug discovery Personalized medicine The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of... Partners - VIVA IN VITRO
Madrid Science Park organizes Madrid Connect 2026 03/09/2026 Access to innovation Drug discovery Industrial biotechnology New Drug Discovery and Biomaterials, two of the event's three main pillars. The gathering offers debates, workshops, and... Partners - Fundación Parque Científico de Madrid
ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat com... 31/08/2026 Healthcare Drug discovery Innovative drugs Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in... Partners - Oryzon Genomics
Neural Omega to present its full molecular mimicry pipeline at BioSpain 2026 31/08/2026 Healthcare Access to innovation Drug discovery From clinical data to drug discovery: Madrid-based biotech Neural Omega will make its international debut at BioSpain... Partners - NEURAL OMEGA
Celtarys Research expands into Targeted Protein Degradation with new tools for PROTAC and ... 28/08/2026 Healthcare Drug discovery Innovative drugs Celtarys Research has expanded its drug discovery portfolio into Targeted Protein Degradation (TPD), launching new... Partners - Celtarys Research
Biobide's DNT assay validated by NIH and US-EPA 01/07/2026 Healthcare Drug discovery International A study led by NIEHS/NIH, with participation from Biobide, the US-EPA, the University of Konstanz, and the IUF-Leibniz... Partners - Biotechnology Assets
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia ... 11/06/2026 Healthcare Drug discovery Innovative drugs In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity... Partners - Oryzon Genomics
Choosing the Right Crystal: Solid Form Optimization for Pharmaceutical Development Online Del 10/06/2026 to 10/06/2026 Healthcare Drug discovery International
Festival of Biologics Basel Switzerland Del 13/10/2026 to 15/10/2026 Healthcare Biosimilars Drug discovery Advanced therapies
